Rad17 Antibody [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-172UV
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Yeast
Applications
Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide made to Schizosaccharomyces pombe RAD17.
Reactivity Notes
Yeast.
Specificity
Reacts with residues 10-23 [STKRSLKKKKIRKI] of the S. pombe RAD17 75 kDA protein.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Rad17 Antibody [DyLight 350]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Rad17
Alternate Names
CCYC, cell cycle checkpoint protein (RAD17), cell cycle checkpoint protein RAD17, FLJ41520, hRad17, R24L, RAD1 (S. pombe) homolog, RAD1 homolog, RAD17 homolog (S. pombe), Rad17-like protein, RAD17Sp, Rad24, RF-C activator 1 homolog, RF-C/activator 1 homolog
Gene Symbol
RAD17
Additional Rad17 Products
Product Documents for Rad17 Antibody [DyLight 350]
Product Specific Notices for Rad17 Antibody [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...